Joseph M Ladowski
Overview
Explore the profile of Joseph M Ladowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shirini K, Ladowski J, Meier R
Xenotransplantation
. 2025 Feb;
32(1):e70027.
PMID: 39999346
This review highlights groundbreaking progress from July to December 2024, including developments in gene-edited pigs, cellular therapies, organ preservation, and transplantation techniques. Recent advancements, particularly in gene-editing technologies and immunosuppressive...
2.
Anwar I, DeLaura I, Ladowski J, Schiliro D, Gao Q, Manook M, et al.
Sci Transl Med
. 2025 Jan;
17(779):eadn8130.
PMID: 39742504
Current desensitization and maintenance immunosuppression regimens for kidney transplantation in sensitized individuals show limited ability to control the posttransplant humoral response, resulting in high rates of antibody-mediated rejection (ABMR) and...
3.
Schwalb A, Anwar I, DeLaura I, Ladowski J, Yoon J, Belloni R, et al.
Front Transplant
. 2024 Dec;
3:1494455.
PMID: 39737411
Objective: Cardiac Allograft Vasculopathy (CAV), a process of vascular damage accelerated by antibody-mediated rejection (AMR), is one of the leading causes of cardiac transplant failure. Proteasome inhibitors (PIs) are utilized...
4.
Ladowski J, Martinino A, Peeler S, Alderete I, Medina C, Bartholomew A, et al.
J Surg Res
. 2024 Oct;
303:275-280.
PMID: 39388992
Introduction: Development of technical skills is a vital component of surgical residency. The use of animal tissues for operative simulation leads to both the loss of animal life and financial...
5.
Ladowski J, Chapman H, DeLaura I, Anwar I, Yoon J, Chen Z, et al.
HLA
. 2024 Jul;
104(1):e15599.
PMID: 39041289
Xenotransplantation is a potential option for individuals for whom an acceptable human allograft is unavailable. Individuals with broadly reactive HLA antibodies due to prior exposure to foreign HLA are potential...
6.
Rowe D, Dalton J, Ladowski J, Soto A, Rhodin K, Migaly J, et al.
J Surg Res
. 2024 Jul;
301:371-377.
PMID: 39029259
Introduction: Resident physicians play an important role in teaching the next generation of health-care providers, yet limited research has explored factors influencing effective teaching, such as preresidency experiences or barriers...
7.
Abraham N, Gao Q, Kahan R, Alderete I, Wang B, Howell D, et al.
Transplant Direct
. 2024 May;
10(6):e1633.
PMID: 38807861
Background: Ex vivo kidney perfusion is an evolving platform that demonstrates promise in preserving and rehabilitating the kidney grafts. Despite this, there is little consensus on the optimal perfusion conditions....
8.
Hu M, Ladowski J, Xu H
Cells
. 2024 May;
13(10.
PMID: 38786047
Autophagy is a highly conserved cellular recycling process which enables eukaryotes to maintain both cellular and overall homeostasis through the catabolic breakdown of intracellular components or the selective degradation of...
9.
Ladowski J, Tector M, Martens G, Wang Z, Burlak C, Reyes L, et al.
Xenotransplantation
. 2024 May;
31(3):e12862.
PMID: 38761019
Prolonged survival in preclinical renal xenotransplantation demonstrates that early antibody mediated rejection (AMR) can be overcome. It is now critical to evaluate and understand the pathobiology of late graft failure...
10.
Howell T, Ladowski J, Nash A, Rhodin K, Tracy E, Migaly J, et al.
J Surg Res
. 2024 May;
299:155-162.
PMID: 38759331
Introduction: Responses to COVID-19 within medical education prompted significant changes to the surgical clerkship. We analyzed the changes in medical student end of course feedback before and after the COVID-19...